{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:02:12Z","timestamp":1790661732715,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nbd.2019.03.028","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T19:18:42Z","timestamp":1553714322000},"page":"217-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1448-124X","authenticated-orcid":false,"given":"Nicolas","family":"Sergeant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vingtdeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Eddarkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Le Fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"Caillierez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Obriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Emmanuel","family":"Larchanch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Farce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Coevoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Carato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kouach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Descat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dallemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bu\u00e9e-Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Hamdane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3446","authenticated-orcid":false,"given":"Patricia","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.03.028_bb0005","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1074\/jbc.M113.530907","article-title":"Signature \u03b2 amyloid profiles are produced by different \u03b3-secretase complexes","volume":"289","author":"Acx","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0010","series-title":"Sulfate Salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, Preparation Thereof and Use of the Same","author":"Barrier","year":"2012"},{"key":"10.1016\/j.nbd.2019.03.028_bb0015","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M112.446070","article-title":"Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease","volume":"288","author":"Barsuto-Islas","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/156720509787602843","article-title":"Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease","volume":"6","author":"Belarbi","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2019.03.028_bb0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.nbd.2011.04.022","article-title":"Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology","volume":"43","author":"Belarbi","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2019.03.028_bb0030","article-title":"Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes","author":"Bretteville","year":"1999","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nbd.2019.03.028_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056870","article-title":"Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease","volume":"8","author":"Capurro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2019.03.028_bb0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ardp.201300074","article-title":"Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease","volume":"346","author":"Chen","year":"2013","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.nbd.2019.03.028_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimer's Dement Transl. Res. Clin. Interv."},{"key":"10.1016\/j.nbd.2019.03.028_bb0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00023.2009","article-title":"Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process","volume":"90","author":"De Strooper","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2019.03.028_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/srep26758","article-title":"AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo","volume":"6","author":"Domise","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.03.028_bb0070","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.03.028_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"86","key":"10.1016\/j.nbd.2019.03.028_bb0080","doi-asserted-by":"crossref","DOI":"10.3791\/51339-v","article-title":"Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting","author":"Fernandez-Gomez","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2019.03.028_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1211\/0022357011775046","article-title":"Synthesis and in-vitro anticancer evaluation of bistacrine congeners","volume":"53","author":"Hu","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.nbd.2019.03.028_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-7-48","article-title":"Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway","volume":"7","author":"Inoue","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2019.03.028_bb0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.nbd.2019.03.028_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nlm.2010.12.005","article-title":"Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission","volume":"95","author":"Van der Jeugd","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymeth.2014.11.021","article-title":"LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells","volume":"75","author":"Jiang","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2019.03.028_bb0115","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1016\/j.bmc.2013.05.028","article-title":"Design, synthesis and neuroprotective evaluation of novel tacrine\u2013benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease","volume":"21","author":"Keri","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2019.03.028_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2019.03.028_bb0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/ALN.0b013e31824be8c7","article-title":"Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment","volume":"116","author":"Le Freche","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nbd.2019.03.028_bb0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.03.028_bb0135","series-title":"Use of 1,4-bis(3-aminopropyl) Piperazine Derivatives in Therapy","author":"Melnyk","year":"2006"},{"key":"10.1016\/j.nbd.2019.03.028_bb0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cn5003013","article-title":"Chloroquine and chloroquine related compounds as a model for the design of anti-Alzheimer compounds","volume":"6","author":"Melnyk","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.028_bb0145","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2174\/092986708785909067","article-title":"Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease","volume":"15","author":"Munoz-Torrero","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0150","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.neurobiolaging.2013.01.008","article-title":"Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation","volume":"34","author":"Nijholt","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2019.03.028_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative diseases","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.03.028_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-4159.2011.07475.x","article-title":"The physiology of the \u03b2-amyloid precursor protein intracellular domain AICD","volume":"120","author":"Pardossi-Piquard","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0165","first-page":"2190","article-title":"The autophagy-related protein beclin1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2019.03.028_bb0170","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.15252\/emmm.201303671","article-title":"Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB","volume":"6","author":"Polito","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2019.03.028_bb0175","first-page":"895","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease","volume":"129","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2019.03.028_bb0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/jm020960r","article-title":"Synthesis and in vitro and in vivo antimalarial activity of N1-(7-Chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives","volume":"46","author":"Ryckebusch","year":"2003","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2019.03.028_bb2000","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1046\/j.1471-4159.1997.69020834.x","article-title":"Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications","volume":"69","author":"Sergeant","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0185","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1046\/j.1471-4159.1999.0721243.x","article-title":"Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively \u00ab exon 10 \u00bb isoforms","volume":"72","author":"Sergeant","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1471-4159.2002.00901.x","article-title":"Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease","volume":"81","author":"Sergeant","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0195","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.028_bb0200","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00401-015-1415-2","article-title":"Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau","volume":"129","author":"Takahashi","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2019.03.028_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13041-014-0054-1","article-title":"The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid","volume":"7","author":"Tam","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.nbd.2019.03.028_bb0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","article-title":"Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach","volume":"9","author":"Troquier","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.03.028_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-4159.2011.07477.x","article-title":"Identification and biology of \u03b1-secretase","volume":"120","author":"Vingtdeux","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0220","doi-asserted-by":"crossref","first-page":"18197","DOI":"10.1074\/jbc.M609475200","article-title":"Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies","volume":"282","author":"Vingtdeux","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0225","doi-asserted-by":"crossref","first-page":"33258","DOI":"10.1074\/jbc.M114.591792","article-title":"Cyclopamine modulates \u03b3-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation","volume":"289","author":"Vorobyeva","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.028_bb0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.celrep.2013.12.008","article-title":"Snapin-mediated BACE1 retrograde transport is essential for its degradation in lysosomes and regulation of APP processing in neurons","volume":"6","author":"Ye","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.03.028_bb0235","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.3700","article-title":"Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease","volume":"20","author":"Zhang","year":"2014","journal-title":"Nat. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118303279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118303279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:13:51Z","timestamp":1760850831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118303279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"alternative-id":["S0969996118303279"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.028","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}